Skip to Content
Merck

Oral insulin delivery by means of solid lipid nanoparticles.

International journal of nanomedicine (2008-01-22)
Bruno Sarmento, Susana Martins, Domingos Ferreira, Eliana B Souto
ABSTRACT

The aim of this work was to produce and characterize cetyl palmitate-based solid lipid nanoparticles (SLN) containing insulin, and to evaluate the potential of these colloidal carriers for oral administration. SLN were prepared by a modified solvent emulsification-evaporation method based on a w/o/w double emulsion. The particle size, zeta potential and association efficiency of unloaded and insulin-loaded SLN were determined and were found to be around 350 nm, negatively charged and the insulin association efficiency was over 43%. After oral administration of insulin-loaded SLN to diabetic rats, a considerable hypoglycemic effect was observed during 24 hours. These results demonstrated that SLN promote the oral absorption of insulin.

MATERIALS
Product Number
Brand
Product Description

Supelco
Cetyl Palmitate, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Palmityl palmitate, ≥99%